GOODWILL AND OTHER INTANGIBLE ASSETS

6 Months Ended

Apr. 30, 2013

Goodwill and Intangible Assets Disclosure [Abstract]

8. GOODWILL AND OTHER INTANGIBLE ASSETS

The following table presents goodwill balances and the movements for each of our reportable segments during the six months ended April 30, 2013:



	Life Sciences		Chemical Analysis		Diagnostics and Genomics		Electronic Measurement			Total
	(in millions)
Goodwill as of October 31, 2012	$	347	$	756	$	1,464	$	458		$	3,025
Foreign currency translation impact	—		—		19		(48		)	(29		)
Goodwill arising from acquisitions/adjustments	—		—		11		(1		)	10
Goodwill as of April 30, 2013	$	347	$	756	$	1,494	$	409		$	3,006

The components of other intangibles as of April 30, 2013 and October 31, 2012 are shown in the table below:



	Purchased Other Intangible Assets
	Gross Carrying Amount		Accumulated Amortization and Impairments		Net Book Value
	(in millions)
As of October 31, 2012:
Purchased technology	$	849	$	333	$	516
Backlog	14		14		—
Trademark/Tradename	168		27		141
Customer relationships	391		155		236
Total amortizable intangible assets	1,422		529		893
In-Process R&D	193		—		193
Total	$	1,615	$	529	$	1,086
As of April 30, 2013:
Purchased technology	1,005		398		607
Backlog	14		14		—
Trademark/Tradename	172		37		135
Customer relationships	391		182		209
Total amortizable intangible assets	1,582		631		951
In-Process R&D	44		—		44
Total	$	1,626	$	631	$	995

During the six months ended April 30, 2013, we recorded additions to goodwill of $10 million primarily related to the acquisition of two businesses. During the three and six months ended April 30, 2012, we recorded additions to goodwill of $14 million and $53 million, respectively. During the six months ended April 30, 2013, we recorded additions to other intangible assets of $1 million. During the three and six months ended April 30, 2012, we recorded additions to other intangible assets of $8 million and $24 million, respectively. During the three and six months ended April 30, 2013, intangible assets decreased by $23 million and increased by $10 million, respectively, due to the impact of foreign exchange translation. During the three and six months ended April 30, 2013, we transferred $125 million and $147 million, respectively, from in-process R&D to purchased technology as projects were completed. We recorded an impairment of $1 million for the three and six months ended April 30, 2013 due to the cancellation of an IPR&D project.

Amortization of intangible assets was $50 million and $101 million for the three and six months ended April 30, 2013, respectively. Amortization of intangible assets was $26 million and $53 million for the three and six months ended April 30, 2012, respectively. Future amortization expense related to existing finite-lived purchased intangible assets is estimated to be $106 million for the remainder of 2013, $206 million for 2014, $187 million for 2015, $154 million for 2016, $103 million for 2017, $66 million for 2018, and $129 million thereafter.

- Definition

The entire disclosure for the aggregate amount of goodwill and a description of intangible assets, which may include (a) for amortizable intangible assets (also referred to as finite-lived intangible assets), the carrying amount, the amount of any significant residual value, and the weighted-average amortization period, (b) for intangible assets not subject to amortization (also referred to as indefinite-lived intangible assets), the carrying amount, and (c) the amount of research and development assets acquired and written off in the period, including the line item in the income statement in which the amounts written off are aggregated, if not readily apparent from the income statement. Also discloses (a) for amortizable intangibles assets in total and by major class, the gross carrying amount and accumulated amortization, the total amortization expense for the period, and the estimated aggregate amortization expense for each of the five succeeding fiscal years, (b) for intangible assets not subject to amortization the carrying amount in total and by major class, and (c) for goodwill, in total and for each reportable segment, the changes in the carrying amount of goodwill during the period (including the aggregate amount of goodwill acquired, the aggregate amount of impairment losses recognized, and the amount of goodwill included in the gain (loss) on disposal of a reporting unit). If any part of goodwill has not been allocated to a reportable segment, discloses the unallocated amount and the reasons for not allocating. For each impairment loss recognized related to an intangible asset (excluding goodwill), discloses: (a) a description of the impaired intangible asset and the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method for determining fair value, (c) the caption in the income statement or the statement of activities in which the impairment loss is aggregated, and (d) the segment in which the impaired intangible asset is reported. For each goodwill impairment loss recognized, discloses: (a) a description of the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method of determining the fair value of the associated reporting unit, and (c) if a recognized impairment loss is an estimate not finalized and the reasons why the estimate is not final. May also disclose the nature and amount of any significant adjustments made to a previous estimate of an impairment loss.

+ References+ Details